[Gender-Specific Medicine and Shared Decision-Making in Parkinson's Disease].

Sex differences have been reported to influence the clinical symptoms of Parkinson's disease and the pharmacokinetics and side effects of anti-Parkinsonian drugs. However, these aspects have rarely been considered in clinical practice. Information regarding drug therapy during pregnancy is insufficient owing to the high proportion of elderly patients. Device-aided therapies are used to treat motor complications in patients with advanced Parkinson's disease. As it is a highly invasive therapy, shared decision-making is important for its introduction.